Brief: TherapeuticsMD Announces Underwritten Public Offering Of Its Common Stock
10/02/2021 21:16
Feb 10 (Reuters) - TherapeuticsMD Inc TXMD.O :
* THERAPEUTICSMD ANNOUNCES UNDERWRITTEN PUBLIC OFFERING OF
ITS
COMMON STOCK
* THERAPEUTICSMD INC - INTENDS TO USE NET PROCEEDS FROM
OFFERING
FOR COMMERCIALIZATION OF ITS THREE FDA-APPROVED PRODUCTS
Source text for Eikon: ID:nBw2TsMM5a
Further company coverage: TXMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TherapeuticsMD
See all newsBrief: TherapeuticsMD Announces First Quarter 2026 Financial Results
TherapeuticsMD swings to Q1 net income as license revenue rises
TherapeuticsMD swings to Q3 profit, license revenue climbs
Brief: TherapeuticsMD Q1 Operating Expenses USD 1.264 Million
Brief: Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract